Recent Articles

Stocks Slump Amid Deutsche Bank Fears

In the end, the Dow Jones lost 1.1%, the S&P 500 lost 0.9%, the Nasdaq lost 0.9% and the Russell 2000 lost 1.4%. More 

Mylan NV (MYL) Scandal Taking Down the Generic Drug Sector

Mylan’s is an easy scandal to understand, and it has delivered an easy villain, making MYL stock an uncomfortable place for investors. More 

3 Stocks to Watch Tuesday: Kite Pharma Inc (KITE), Array Biopharma Inc (ARRY) and Mylan NV (MYL)

Kite Pharma (KITE) has promising results from its cancer drug's trial, Array Biopharma (ARRY) still is cruising on Monday's news and Mylan (MYL) won't let its scandal die. More 

4 Stocks That Will Suffer If Hillary Clinton Wins

A win for the Democrats could be problematic for some U.S. corporations, as Hillary Clinton’s agenda could cause MYL, AAPL, XOM and JPM to tank. More 

How Can an Ethical Investor Stay in This Market? (HPQ)

HP Inc (HPQ) created a monopoly with a software update that makes customers buy its cartridges. It's just one of several ethics issues that investors have to hold their noses near. More 

UnitedHealth Group Inc (UNH) May Fall Victim to EpiPen Outrage

Mylan may be putting the blame on pharmacy benefit managers for EpiPen's price increase, and UnitedHealth (UNH) is among the biggest. More 

5 Dow Jones Titans Getting Pulled Into the Selloff

Friday's fall from grace is putting a number of Dow Jones stocks at risk of further losses. Here are five to watch. More